Category: News

The objective of the pilot and feasibility program is to provide seed money of up to $25K for 1 year to initiate new and innovative projects in the areas of phenotyping and precision medicine that will enhance work being done in the CCCR.

Dr. Callahan provides important insights into causes, consequences, and ways that specific programs that can help reduce disparities in outcomes for patients.

The "BASE" study, now published in The Lancet Rheumatology, found mortality & AESIs among SLE patients taking Benlysta similar to placebo.

In both his on-air interview segment, as well as a more extensive Zoom interview available online, Dr. Kim stressed that allergic reactions to the new vaccine are likely to be rare, with the risks extremely low compared to the benefits of getting the vaccine.

As the season of giving approaches, we hope you will join us on Tuesday, December 1 for a day that will give us all the chance to come together to do a little good for others.

The course is available for free on the AAAAI website.

ACR hosted the meeting remotely from November 5-9.

The award is presented to one clinical scientist yearly, for making outstanding contributions to the field of Rheumatology.

The "Joint Action" podcast explores what this national coalition is doing to reduce the impact of OA on individuals and our communities.

The team has launched an innovative outpatient program where providers delable penicillin allergy through penicillin allergy assessments.